Performance of HPV E6/E7 mRNA Assay as Primary Screening Test. Results from the NTCC2 Trial.

Authors:

Giorgi Rossi P, Ronco G, Mancuso P, Carozzi F, Allia E, Bisanzi S, Gillio-Tos A, De Marco L, Rizzolo R, Gustinucci D, Del Mistro A, Frayle H, Confortini M, Iossa A, Cesarini E, Bulletti S, Passamonti B, Gori S, Toniolo L, Barca A, Bonvicini L, Venturelli F, Benevolo M; NTCC2 Working Group.

Source:

Int J Cancer 2022; 151: 1047-1058. doi: 10.1002/ijc.34120. Epub 2022 Jun 7. PMID: 35579975 (IF 7.316)

This site uses technical, analytics and third-party cookies. By continuing to browse, you accept the use of cookies.